Across TCGA pan-cancer cohorts, ATP5PDP3 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of ATP5PDP3’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where ATP5PDP3 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types ATP5PDP3 is over-expressed in tumor, although a few such as STAD show the opposite, repressed pattern.

COAD, STAD, and BRCA are the cancer types where ATP5PDP3 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in ATP5PDP3 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Female	All	+0.396	.014	4	view →
STAD	Male	II,III,IV	−0.163	.024	4	view →
BRCA	All	III,IV	+0.030	.021	2	view →
LIHC	All	All	+0.127	.033	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

Exploration

Same gene, other analysis: ATP5PDP3 RNA expression & survival · all ATP5PDP3 data types